US Stock MarketDetailed Quotes
NLSP NLS Pharmaceutics
- 0.2050
- +0.0029+1.43%
Close Jul 11 16:00 ET
- 0.2085
- +0.0035+1.71%
Post 19:59 ET
9.57MMarket Cap-640P/E (TTM)
0.2100High0.1943Low2.69MVolume0.2019Open0.2021Pre Close544.75KTurnover10.24%Turnover RatioLossP/E (Static)46.66MShares1.205052wk High-1.08P/B5.38MFloat Cap0.111252wk Low--Dividend TTM26.22MShs Float7.3500Historical High--Div YieldTTM7.77%Amplitude0.1112Historical Low0.2020Avg Price1Lot Size
About NLS Pharmaceutics Company
NLS Pharmaceutics AG engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders. These disorders include narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as ADHD. The company was founded by Ronald Hafner and Alexander Zwyer in August 2015 and is headquartered in Stans, Switzerland.
Company Profile
SymbolNLSP
Company NameNLS Pharmaceutics
Listing DateJan 29, 2021
Issue Price4.15
Founded2015
CEOMr. Alexander Zwyer
MarketNASDAQ
Employees4
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressAlter Postplatz 2
CityStans
ProvinceNidwalden
CountrySwitzerland
Zip Code6370
Phone41-41-618-80-00
Websitehttp://nlspharma.com
Company Executives
- Name
- Position
- Salary
- Alexander Zwyer
- Chief Executive Officer and Director
- --
- Dr. Eric Konofal, M.D.
- Chief Scientific Officer
- --
- George Apostol
- Chief Medical Officer and Global Head of Research and Development
- --
- Elena Thyen-Pighin
- Chief Financial Officer and Head of Finance and Human Resources
- --
- Ronald Hafner
- Chairman of the Board
- --
- Audrey Greenberg
- Independent Director
- --
- Gian-Marco Rinaldi
- Independent Director
- --
- Florence Allouche Aknin
- Independent Director
- --
- Claudio L. A. Bassetti
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
